Persistent production of TH2-type cytokines and polyclonal B cell activation after chronic administration of staphylococcal enterotoxin B in mice

Journal of Autoimmunity

Volumn 9, Issue 5, 1996, Pages 609-615

  Florquin, Sandrine ^a,c   Amraoui, Zoulikka ^a   Goldman, Michel ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Glomerulonephritis; IL 10; IL 4; Polyclonal B cell activation; Staphylococcal enterotoxin B; Superantigen; TH2

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ANERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD LEVEL; CONTROLLED STUDY; ETIOLOGY; HELPER CELL; HYPERIMMUNOGLOBULINEMIA; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0030272633     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0080     Document Type: Article

References (29)

1. 1. Kappler J., Kotzin B., Herron L., Gelfand E., Bigler R., Boylston A., Carrel S., Posnett D., Choi Y., Marrack P. 1989. Vβ-specific stimulation of human T cells by stapylococcal toxins. Science 244: 811-813
2. 2. Herrmann T., Baschieri S., Lees R., MacDonald R. 1992. In vivo response of CD4+ and CD8+ cells to bacterial superantigens. Eur. J. Immunol. 22: 1935-1938
3. 3. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P., Wagner H. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphyloccocal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175: 91-98
4. 4. Florquin S., Amraoui Z., Abramowicz D., Goldman M. 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153: 2618-2623
5. 5. Marrack P., Blackman M., Kushnir E., Kappler J. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171: 455-464
6. 6. Kawabe Y., Ochi A. 1991. Programmed cell death and extrathymic reduction of Vβ8 CD4 T cells in mice tolerant to staphylococcal enterotoxin B. Nature 349: 245-248
7. 7. Kawabe Y., Ochi A. 1990. Selective anergy of Vβ8, CD4 T cells in staphylococcal enterotoxin B-primed mice. J. Exp. Med. 172: 1065-1070
8. 8. Rellahan B., Jones L., Kruisbeek A., Fry A., Matis L. 1990. In vivo induction of anergy in peripheral Vβ8 T cells by staphylococcal enterotoxin B. J. Exp. Med. 172: 1091-1100
9. 9. Florquin S., Amraoui Z., Goldman M. 1995. T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-γ and interleukin-10 secretion. Eur. J. Immunol. 25: 1148-1153
10. 10. Durez P., Abramowicz D., Gerard Cl, Van Mechelen M., Amraoui Z., Dubois C., Leo O., Velu T., Goldman M. 1993. In vivo induction of interleukin-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J. Exp. Med. 177: 551-555
11. 11. Goldman M., Feng H., Engers H., Hochman A., Louis J., Lambert P 1983. Autoimmunity and immune complex disease after neonatal induction of transplantation tolerance in mice. J. Immunol. 131: 251-258
12. 12. Florquin S., Abramowicz D., de Heer E., Bruijn J., Doutrelpont J., Goldman M., Hoedemaeker P 1991. Renal immunopathology in murine host-versus-graft disease. Kidney Int. 40: 852-861
13. 13. Coligan J., Kruisbeek A., Margulies D., Shevach E., Strober W. 1992. Current Protocols in Immunology. 1992. Greene Publishing Associates and Wiley-Interscience,. New-York, p. 3.5.1
14. 14. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D., Kastelein R., Moore K., Banchereau J. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89: 1890-1893
15. 15. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 Mice. J. Exp. Med. 179: 305-310
16. 16. Llorente L., Zou W. P., Levy Y, Richaudpatin Y., Wijdenes J., Alcocervarela J., Morelfourrier B., Brouet J. C., Alarcón-Segovia D., Galanaud P., Emilie D. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181: 839-844
17. 17. Tumang J., Cherniack P., Gietl D., Cole B., Russo C., Crow M., Friedman S. 1991. T helper cell-dependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses. J. Immunol. 147: 432-438
18. 18. He X., Goronzy J., Weyand C. 1992. Selective induction of rheumatoid factor by superantigens and human helper T cells. J. Clin Invest. 89: 673-680
19. 19. Gazzinelli R., Makino M., Chattopadhyay U., Snapper C., Sher A., Hügin A., Morse H. 1992. CD4+ subset regulation in viral infection: Preferential activation of TH2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 148: 182-188
20. 20. Goldman M., Druet P., Gleichmann E. 1991. A role for TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol, Today 12: 223-227
21. 21. Doutrelepont J.M., Moser M., Leo O., Abramowicz D., Vanderhaegen M., Urbain J., Goldman M. 1991. Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4. Clin. Exp. Immunol. 832: 133-136
22. 22. De Wit D., Van Mechelen M., Zanin C., Doutrelepont J., Velu T., Gérard C., Abramowicz D., Scheerlinck J., De Baetselier P., Urbain J., Leo O., Goldman M., Moser M. 1993. Preferential activation of TH2 cells in chronic graft-versus-host reaction. J. Immunol. 150: 361-366
23. 23. Pietsch P., Vohr H., Degitz K., Gleichmann E. 1989. Immunopathological signs inducible by mercury compounds. II. HgC12 and gold sodium thiomalate enhance serum IgE and IgG concentration in susceptible mouse strains. Int. Arch. Allergy Appl. Immun. 90: 47-53
24. 24. Tournade H., Guery J.C., Pasquier R., Nochy D., Hinglais N., Guilbert B., Druet P., Pelletier L. 1991. Experimental gold-induced autoimmunity. Nephrol. Dial. Transplant. 6: 621-630
25. 25. Bruijn J., Hogendoorn P., Corver W., van den Broak L., Hoedemaeker P., Fleuren G. 1990. Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin. Exp. Immunol. 79: 115-128
26. 26. Sapin C., Druet E., Druet P. 1977. Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin. Exp. Immunol. 28: 173-179
27. 27. Paliard X., West S., Lafferty J., Clements J., Kappler J., Marrack P., Kotzin B. 1991. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253: 325-329
28. 28. Legras F., Martin T., Knapp A., Pasquali J. 1994. Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor Vβ regions depending on the stage of the disease. Eur. J. Immunol. 24: 181-185
29. 29. Koyama A., Kobayachi M., Yamaguchi N., Yamagata K., Takano K., Nakajima M., Irie F., Goto M., Igarashi M., Iitsuka T., Aoki Y., Sakurai H., Sakurayama N., Fukao K. 1995. Glomerulonephritis associated with MRSA infection: A possible role of bacterial superantigen. Kidney Int. 47: 216-227